Drugs agency reminds companies of duty to report side effectsBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7343.938/b (Published 20 April 2002) Cite this as: BMJ 2002;324:938
- Rory Watson
The London based European Agency for the Evaluation of Medicinal Products is reminding pharmaceutical companies of their responsibility to report any previously unknown side effects that might emerge when new drugs are put on the market.
The initiative reflects the agency's determination since the start of the year to emphasise its establishment of a strong pharmaceutical vigilance system to ensure the safety of drugs, in addition to its role of granting licences for new products.
Under existing rules companies have to report any adverse effects …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial